Correlation Between Pfizer and Level

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Level at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Level into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Level 3 Financing, you can compare the effects of market volatilities on Pfizer and Level and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Level. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Level.

Diversification Opportunities for Pfizer and Level

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pfizer and Level is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Level 3 Financing in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Level 3 Financing and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Level. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Level 3 Financing has no effect on the direction of Pfizer i.e., Pfizer and Level go up and down completely randomly.

Pair Corralation between Pfizer and Level

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Level. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 4.82 times less risky than Level. The stock trades about -0.06 of its potential returns per unit of risk. The Level 3 Financing is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  8,834  in Level 3 Financing on October 7, 2024 and sell it today you would lose (338.00) from holding Level 3 Financing or give up 3.83% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy78.83%
ValuesDaily Returns

Pfizer Inc  vs.  Level 3 Financing

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Level 3 Financing 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Level 3 Financing are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Level may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pfizer and Level Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Level

The main advantage of trading using opposite Pfizer and Level positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Level can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Level will offset losses from the drop in Level's long position.
The idea behind Pfizer Inc and Level 3 Financing pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data